Health Care Solutions Durable Medical Equipment & Medical Supplies Location: 05673 State Route 15, Bryan, Ohio 43506 Phone: (419) 636-4189 |
Cvs Pharmacy #06181 Durable Medical Equipment & Medical Supplies Location: 341 W High St, Bryan, Ohio 43506 Phone: (419) 636-5021 |
Rite Aid Pharmacy 02347 Durable Medical Equipment & Medical Supplies Location: 1221 W High St, Bryan, Ohio 43506 Phone: (419) 636-6142 |
Walmart Pharmacy 10-2191 Durable Medical Equipment & Medical Supplies Location: 1215 S Main St, Bryan, Ohio 43506 Phone: (419) 636-9153 |
Walgreens #10579 Durable Medical Equipment & Medical Supplies Location: 403 S Main St, Bryan, Ohio 43506 Phone: (419) 636-0613 |
Mantel Home Health Center Durable Medical Equipment & Medical Supplies Location: 442 W High St, Bryan, Ohio 43506 Phone: (419) 636-8010 |
Marshall-kloene Orthopedics Inc DME Supplier - Customized Equipment Location: 6902 Us 127, Bryan, Ohio 43506 Phone: (419) 893-0748 |
Peters Family Eyecare Medicare Supplier Location: 219 S Main St, Bryan, Ohio 43506 Phone: (419) 636-3937 |
Northwest Ohio Eyecare Medicare Supplier Location: 1313 W High St, Bryan, Ohio 43506 Phone: (419) 636-1531 |
Daavlin Distributing Company Durable Medical Equipment & Medical Supplies Location: 205 W Bement St, Bryan, Ohio 43506 Phone: (419) 636-6304 |
News Archive
The immune system cells known as T cells play a central role in the body's ability to fight infections and cancer. For decades, however, details of the molecular signaling process that leads to T cell activation have remained a mystery.
Republicans are preparing a spate of procedural objections to use in the event Senate Democrats try to employ budget reconciliation rules to advance their health reform proposals.
Investigators are hitting a wall in an insider-trading probe of how a government funding decision made its way to investors before it was officially released, according to people familiar with the probe.
The U.S. Food and Drug Administration (FDA) today issued draft regulatory guidance for the medical device industry on commercially distributed active ingredients of medical tests called Analyte Specific Reagents (ASRs).
UCB announced today that the European Commission (EC) has approved Vimpat (lacosamide) as adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 16 years and older. Vimpat is the first new antiepileptic drug (AED) for partial-onset seizures in three years and offers a new treatment option for European patients living with uncontrolled partial-onset epilepsy.
› Verified 2 days ago